Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis

Clinical trial NCT01758510 · COMPLETED

Trial details

NCT number: NCT01758510
Sponsor: Hanyang University Seoul Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis Motor Neuron Disease Neuromuscular Disease Neurodegenerative Disease Central Nervous System Disease

Start date: 2012-12-01
Primary completion: 2017-04-10
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.